Tu SM - Search Results

1

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. Among authors: tu sm. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

2

Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases.

Park DS, Vassilopoulou Sellin R, Tu S. Park DS, et al. Urology. 2001 Jul;58(1):105. doi: 10.1016/s0090-4295(01)01119-0. Urology. 2001. PMID: 11445494

3

Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features.

Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Tu SM, et al. Cancer. 2002 May 15;94(10):2610-7. doi: 10.1002/cncr.10546. Cancer. 2002. PMID: 12173328 Free article.

4

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.

Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Tannir N, et al. Among authors: tu sm. Cancer. 2006 Aug 1;107(3):497-505. doi: 10.1002/cncr.22038. Cancer. 2006. PMID: 16795067 Free article. Clinical Trial.

5

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Among authors: tu sm. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

6

Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.

Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Spiess PE, et al. Among authors: tu sm. Cancer. 2006 Oct 1;107(7):1483-90. doi: 10.1002/cncr.22182. Cancer. 2006. PMID: 16944541 Free article.

7

Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.

Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, Hitzhusen K, Millikan RE, Pisters LL. Leibovici D, et al. Among authors: tu sm. Cancer. 2007 Jan 15;109(2):198-204. doi: 10.1002/cncr.22372. Cancer. 2007. PMID: 17171704 Free article.

8

Multilocular cystadenoma and cystadenocarcinoma of the prostate.

Tuziak T, Spiess PE, Abrahams NA, Wrona A, Tu SM, Czerniak B. Tuziak T, et al. Among authors: tu sm. Urol Oncol. 2007 Jan-Feb;25(1):19-25. doi: 10.1016/j.urolonc.2006.01.011. Urol Oncol. 2007. PMID: 17208134 Review.

9

Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.

Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Spiess PE, et al. Among authors: tu sm. J Urol. 2007 Apr;177(4):1330-4; discussion 1334. doi: 10.1016/j.juro.2006.11.086. J Urol. 2007. PMID: 17382725

10

Patient survival after surgery for osseous metastases from renal cell carcinoma.

Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Lin PP, et al. Among authors: tu sm. J Bone Joint Surg Am. 2007 Aug;89(8):1794-801. doi: 10.2106/JBJS.F.00603. J Bone Joint Surg Am. 2007. PMID: 17671020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters